Skip to content
Lower risk Medical device recall · FDA · Published September 23, 2022

LumiraDx SARS-CoV-2 Antigen Kit: Incorrect Product Assignment Risk

LumiraDx recalls SARS-CoV-2 Antigen Liquid Quality Control Kits with incorrect vial lot numbers that may prevent proper testing. Affected kits could show error messages and fail to function correctly.

🇺🇸 FDA recall #Z-0135-2023Medical deviceLumiraDx ›
Take action

Contact the company

Recalling firmLumiraDx221 Crescent St · Waltham, MA 02453-3475
✎ GovInfoNow plain-language explainer

LumiraDx is recalling SARS-CoV-2 Antigen Liquid Quality Control Kits that have incorrect vial lot numbers. This error may cause the kits to display an error message and prevent proper testing, potentially leading to inaccurate results. Read more at govinfonow.com/recall/60028-lumiradx-sars-cov-2-antigen-kit-incorrect-product-assignment-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/60028-lumiradx-sars-cov-2-antigen-kit-incorrect-product-assignment-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0135-2023

Cite this page

“LumiraDx SARS-CoV-2 Antigen Kit: Incorrect Product Assignment Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60028-lumiradx-sars-cov-2-antigen-kit-incorrect-product-assignment-risk. Based on FDA recall #Z-0135-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0135-2023%22&limit=1).

The FDA announced on Sept. 23, 2022, that LumiraDx voluntarily recalled its SARS-CoV-2 Antigen Liquid Quality Control Kit due to incorrect lot number assignments. The error could result in an error message preventing use of the quality control kit. This recall involves 83 kits distributed nationwide.

How to tell if you have it

  • Brand: LumiraDx
  • Product: LumiraDx SARS-CoV-2 Antigen (Ag) Liquid Quality Control Kit
  • Catalog #: L016080109002 (EUA)
  • Batch: 2002204017
  • Positive Control Vial Lot: 1000 1710 0014 0141
  • Negative Control Vial Lot: 1000 1720 0014 0142
  • Expiration Date: 01-Mar-2023

The hazard

The recall involves incorrect assignment of SARS-CoV-2 and Flu A/B lot numbers to the positive and negative vial lot numbers for SARS-CoV-2 Ag Liquid Quality Controls. This misassignment results in an error message that prevents the use of the LQC kit.

Context

GovInfoNow's records show LumiraDx has had four other recalls since Jan. 11, 2021. On April 25, 2023, LumiraDx recalled SteriPack Swabs due to breakage risks, and on June 24, 2022, it recalled SARS-CoV-2 Antibody Test Strips for unapproved modifications. Other recent recalls of similar products include Microbiologics KWIK-STIK Quality Control Kit Recall (Nov. 13, 2025) and Medline Convenience Kits Recall (Jan. 7, 2026).

How to tell if you have this one

Check the vial lot numbers on the kit: Positive Control Vial: 1000 1710 0014 0141 and Negative Control Vial: 1000 1720 0014 0142. The kits were sold with batch number 2002204017 and expire on March 1, 2023.

  • Brand
    LumiraDx
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Lot Numbers

    Verify the vial lot numbers on the kit: Positive Control Vial: 1000 1710 0014 0141 and Negative Control Vial: 1000 1720 0014 0142.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: Sep 23, 202212. FDA classified it Class III: Oct 26, 202223. Published in FDA’s Enforcement Report: Nov 2, 202234. FDA terminated the recall: Dec 13, 2024420222024
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have this product?

Check the vial lot numbers on your kit. If they match the recalled numbers, stop using it and contact LumiraDx for further instructions.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0135-2023 (September 23, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0135-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA